Navigation Links
China Bionanometer Industries (CBIU) Describes their Current Production Capacity and Product Lines

XI'AN, China, April 2, 2008 /Xinhua-PRNewswire-FirstCall/ -- China Bionanometer Industries Corporation (Pink Sheets: CBIU), a leading company in the Nano-BioTech Industry, announces their current production capacity and product lines. The company presently produces nanometer level raw material powder for China's health industry. As a leader in China's new Health Technology Industry, the company gained international attention with the introduction of an Influenza prevention granule at the height of a major Flu outbreak in neighboring Hong Kong.

China BioNanometer's production base includes an intact line of state of the art manufacturing equipment for nanometer level powder molding. The annual production capacity is 100 tons of nanometer level biologic powder body, including four main classes of plant element; propagation albumen, hydrolytic mineral, and substance and activity enriching fungi).

They also produce a daily cosmetic line using nanometer level raw material. The company furnishes their raw materials and prescription to one of the top OEM cosmetic manufactures in China which makes the final top quality product on behalf of the company. This manufacturer makes products for the leading cosmetic companies in the World.

China BioNanometer has a 200 million tablet per year production line constructed according to the GMP (Good Manufacturing Process) standard of China's Food and Health Agency. This production line was one of the first Nanometer level tablet lines passing the State Food and Health Agency's GMP authentication in China's Shaanxi Province.

The company plans to build Landway Biological Nanometer Technology Park in Yangling National Agricultural High-tech Industry Demonstration Area. After the completion of Landway Biological Nanometer Technology Park, the output can reach 500 million tablets per year.

The CEO of the company, Mr. Chen Min, stated, "Good management, state of the art equipment, and strict quality control ensures our ability to continue to conform to China's GMP standard for many products to come.''

About China Bionanometer Industries Corporation

China Bionanometer Industries Corporation is a high-tech enterprise specializing in the research, development, production and sale of nanometer level health food, cosmetics, biological disinfection products, and traditional Chinese medicine, etc. The company has obtained the state authentication for high and new technology enterprises and is also an academician enterprise in the high-tech field. As a high and new technology enterprise that takes scientific research as its base, profiting from the huge benefits brought by technological innovation, the Company establishes an efficient scientific research development system that allows the continuation of the pursuit for newer technologies and industrial development by creating a people-oriented and innovative environment that follows the modern management model.

Forward-looking Statement

Certain information contained in these materials is "forward-looking" information, such as projections, estimates, pro formas, or statements of intentions, expectations or plans. All forward-looking information is subject to known and unknown risks and uncertainties, many of which are outside of the control of the Company. Consequently, actual results may, and probably will, differ materially from the results contemplated in such forward-looking information.

SOURCE China Bionanometer Industries Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss ... to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed ...
(Date:11/27/2015)... ... November 27, 2015 , ... The ... of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a ... component is distributed nationally, through a vast social media strategy and across a ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end ... Microsoft Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership ...
(Date:11/27/2015)... ... 2015 , ... CBD College is proud to announce that on ... accreditation to its Diagnostic Medical Sonography program. CBD College is honored to join this ... colleges and universities in the state of California make the cut. CBD College is ...
(Date:11/27/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk ... Term Support) into its Q-Suite 5.10 product line. , Making the change to ... of Asterisk that will receive not only security fixes, but feature and bug ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... Ein neuer Kombinationsansatz vereint ... --> Ein neuer Kombinationsansatz vereint Immuntherapie ... --> Ein neuer Kombinationsansatz vereint Immuntherapie ... Clinical Cancer Research vom 6. November ... vom 6. November 2015 berichtet. --> ...
(Date:11/26/2015)... Un nuevo enfoque combina la ... cáncer avanzado.   --> Un nuevo ... Bremachlorin para el cáncer avanzado.   --> ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... --> Clinical Cancer Research . --> ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ) ... Pacemaker Market Outlook to 2019 - Rise in Cardiac Disorders ... report to their offering. Boston ... Boston scientific and others. --> ... Biotronik, Boston scientific and others. ...
Breaking Medicine Technology: